HIV-positive TB patients on ART (antiretroviral therapy) in South-East Asia (WHO region)
South-East Asia (WHO region): HIV-positive TB patients on ART (antiretroviral therapy) was 94.0% in 2024. ▲ Rising
Latest (2024)
94.0%
Change on year
down 1.1%
Rank
4th
of 11 groups
All-time high
95.0%
in 2023
All-time low
5.6%
in 2005
Years of data
21
2003–2024
HIV-positive TB patients on ART (antiretroviral therapy) in South-East Asia (WHO region), 2003–2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, hiv-positive tb patients on art (antiretroviral therapy) in South-East Asia (WHO region) stood at 94.0%.
The figure is down 1.1% on the previous year and up 14.6% over ten years.
Over the whole period, hiv-positive tb patients on art (antiretroviral therapy) in South-East Asia (WHO region) peaked at 95.0% in 2023 and was at its lowest, 5.6%, in 2005.
The long-run direction has been consistently rising across the 21 years of available data.
HIV-positive TB patients on ART (antiretroviral therapy) in South-East Asia (WHO region), year by year
| Year | Value | Change |
|---|---|---|
| 2003 | 60.0% | — |
| 2005 | 5.6% | -90.7% |
| 2006 | 31.0% | +453.6% |
| 2007 | 17.0% | -45.2% |
| 2008 | 41.0% | +141.2% |
| 2009 | 50.0% | +22.0% |
| 2010 | 57.0% | +14.0% |
| 2011 | 59.0% | +3.5% |
| 2012 | 59.0% | +0.0% |
| 2013 | 82.0% | +39.0% |
| 2014 | 82.0% | +0.0% |
| 2015 | 82.0% | +0.0% |
| 2016 | 87.0% | +6.1% |
| 2017 | 75.0% | -13.8% |
| 2018 | 86.0% | +14.7% |
| 2019 | 91.0% | +5.8% |
| 2020 | 89.0% | -2.2% |
| 2021 | 89.0% | +0.0% |
| 2022 | 94.0% | +5.6% |
| 2023 | 95.0% | +1.1% |
| 2024 | 94.0% | -1.1% |
Biggest year-on-year movements
Years where HIV-positive TB patients on ART (antiretroviral therapy) in South-East Asia (WHO region) changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2006 | +453.6% | 5.6% | 31.0% |
| 2008 | +141.2% | 17.0% | 41.0% |
| 2005 | -90.7% | 60.0% | 5.6% |
| 2007 | -45.2% | 31.0% | 17.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 34.1% | 5.6% | 60.0% | 6 |
| 2010s | 76.0% | 57.0% | 91.0% | 10 |
| 2020s | 92.2% | 89.0% | 95.0% | 5 |
Countries ranked near South-East Asia (WHO region)
- 1 Seychelles 100.0% compare
- 1 Cape Verde 100.0% compare
- 1 Slovenia 100.0% compare
- 1 Hong Kong 100.0% compare
- 1 Ecuador 100.0% compare
- 1 Burkina Faso 100.0% compare
- 1 Oman 100.0% compare
- 1 Togo 100.0% compare
- 1 Eritrea 100.0% compare
- 1 Serbia 100.0% compare
- 1 Israel 100.0% compare
- 1 Sri Lanka 100.0% compare
- 1 Estonia 100.0% compare
- 1 Brunei 100.0% compare
- 1 Slovakia 100.0% compare
- 1 Bhutan 100.0% compare
- 1 Grenada 100.0% compare
- 1 Armenia 100.0% compare
- 1 Antigua and Barbuda 100.0% compare
- 1 Kuwait 100.0% compare
- 1 Bulgaria 100.0% compare
- 1 Georgia 100.0% compare
- 1 Sierra Leone 100.0% compare
- 1 Bahrain 100.0% compare
- 1 Azerbaijan 100.0% compare
- 1 Egypt 100.0% compare
- 1 Sao Tome and Principe 100.0% compare
- 1 Guinea 100.0% compare
- 1 Tajikistan 100.0% compare
- 1 North Macedonia 100.0% compare
- 1 Saint Lucia 100.0% compare
- 1 Cuba 100.0% compare
- 1 Macao 100.0% compare
- 1 Albania 100.0% compare
- 1 Nicaragua 100.0% compare
- 1 Malta 100.0% compare
- 1 Jordan 100.0% compare
- 1 Mongolia 100.0% compare
- 1 Saint Vincent and the Grenadines 100.0% compare
- 1 Chad 100.0% compare
- 1 Qatar 100.0% compare
- 1 Malawi 100.0% compare
- 1 Iraq 100.0% compare
- 1 Tunisia 100.0% compare
- 1 Montenegro 100.0% compare
- 1 Mauritius 100.0% compare
- 1 Lebanon 100.0% compare
- 1 Marshall Islands 100.0% compare
- 1 Saudi Arabia 100.0% compare
- 1 Panama 100.0% compare
- 1 Comoros 100.0% compare
- 1 Afghanistan 100.0% compare
- 1 Dominica 100.0% compare
- 1 Barbados 100.0% compare
- 1 United Arab Emirates 100.0% compare
- 1 Syria 100.0% compare
More health data for South-East Asia (WHO region)
- Pertussis - number of reported cases, gaps filled 2,449 (2025)
- Total tetanus - number of reported cases, gaps filled 164 (2025)
- Neonatal tetanus - number of reported cases, gaps filled 84 (2025)
- Measles - number of reported cases, gaps filled 19,075 (2025)
- Diphtheria - number of reported cases, gaps filled 3,416 (2025)
- Number of under-five deaths, annual growth rate -4.64 % change on previous year (2024)
- Number of neonatal deaths, annual growth rate -4.57 % change on previous year (2024)
- Number of infant deaths, annual growth rate -4.21 % change on previous year (2024)
- Measles - number of reported cases, annual growth rate -30.44 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate -67.98 % change on previous year (2025)
Frequently asked questions
- What is hiv-positive tb patients on art (antiretroviral therapy) in South-East Asia (WHO region)?
- Hiv-positive tb patients on art (antiretroviral therapy) in South-East Asia (WHO region) was 94.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hiv-positive tb patients on art (antiretroviral therapy) recorded in South-East Asia (WHO region)?
- The highest recorded value was 95.0% in 2023.
- What is the lowest hiv-positive tb patients on art (antiretroviral therapy) recorded in South-East Asia (WHO region)?
- The lowest recorded value was 5.6% in 2005.
- How does South-East Asia (WHO region) rank for hiv-positive tb patients on art (antiretroviral therapy)?
- South-East Asia (WHO region) ranks 4th out of 11 groups with data for 2024.
- Is hiv-positive tb patients on art (antiretroviral therapy) rising or falling in South-East Asia (WHO region)?
- Over the last ten years it is up 14.6%. The long-run trend across the full record is rising.
- Where does this South-East Asia (WHO region) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 21 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).